AR018925A1 - Derivados de triazolo-piridazina como ligandos para receptores de gaba, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento. - Google Patents
Derivados de triazolo-piridazina como ligandos para receptores de gaba, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento.Info
- Publication number
- AR018925A1 AR018925A1 ARP990103008A ARP990103008A AR018925A1 AR 018925 A1 AR018925 A1 AR 018925A1 AR P990103008 A ARP990103008 A AR P990103008A AR P990103008 A ARP990103008 A AR P990103008A AR 018925 A1 AR018925 A1 AR 018925A1
- Authority
- AR
- Argentina
- Prior art keywords
- triazolo
- manufacture
- preparation
- pharmaceutical compositions
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Derivados de triazolo-piridazinas que comprende 7-(1,1-dimetiletil)-6-(2-etil-2H-1,2,4-triazol-3-ilmetoxi)-3-(2-fluorofenil)-1,2,4-triazolo[4,3-b]-piridazina y 7-ciclobutil-3-(2,6-difluorofenil)-6-(2-metil-2H-1,2,4-triazol-3-ilmetoxi)-1,2,4-triazolo[ 4,3-b]piridazina, y sus sales farmacéuticamenteaceptables, son ligandos selectivos para receptores de GABA A, teniendo en particular alta afinidad para las subunidades alfa2 y/o alfa3 de éstos,y correspondientemente son beneficiosas en eltratamiento y/o la prevencion de trastornos del sistema nervioso central, inclusive ansiedad yconvulsiones. Además se describe un procedimiento para su preparacion, composiciones farmacéuticas que los comprenden y el uso de los mismospara lamanufactura de un m edicamento.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9813576.7A GB9813576D0 (en) | 1998-06-24 | 1998-06-24 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018925A1 true AR018925A1 (es) | 2001-12-12 |
Family
ID=10834265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990103008A AR018925A1 (es) | 1998-06-24 | 1999-06-23 | Derivados de triazolo-piridazina como ligandos para receptores de gaba, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento. |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6630471B1 (es) |
| EP (1) | EP1090004B1 (es) |
| JP (1) | JP4749545B2 (es) |
| KR (1) | KR100604108B1 (es) |
| CN (1) | CN1138779C (es) |
| AR (1) | AR018925A1 (es) |
| AT (1) | ATE239730T1 (es) |
| AU (1) | AU757315B2 (es) |
| BG (1) | BG64989B1 (es) |
| BR (1) | BR9911563A (es) |
| CA (1) | CA2335328C (es) |
| CO (1) | CO5031239A1 (es) |
| CZ (1) | CZ291409B6 (es) |
| DE (1) | DE69907675T2 (es) |
| EA (1) | EA003332B1 (es) |
| EE (1) | EE200000767A (es) |
| ES (1) | ES2196824T3 (es) |
| GB (1) | GB9813576D0 (es) |
| GE (1) | GEP20033143B (es) |
| HR (1) | HRP20000879A2 (es) |
| HU (1) | HUP0102894A3 (es) |
| ID (1) | ID27771A (es) |
| IL (2) | IL139775A0 (es) |
| IS (1) | IS2258B (es) |
| MY (1) | MY124341A (es) |
| NO (1) | NO317992B1 (es) |
| NZ (1) | NZ508290A (es) |
| PE (1) | PE20000710A1 (es) |
| PL (1) | PL204650B1 (es) |
| RS (1) | RS49746B (es) |
| SK (1) | SK285307B6 (es) |
| TR (1) | TR200003789T2 (es) |
| TW (1) | TWI222449B (es) |
| WO (1) | WO1999067245A1 (es) |
| ZA (1) | ZA200007485B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2345443A (en) * | 1999-01-08 | 2000-07-12 | Merck Sharp & Dohme | Use of triazolo-pyridazines for treating premenstrual syndrome |
| US20050042194A1 (en) | 2000-05-11 | 2005-02-24 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| GB0111191D0 (en) * | 2001-05-08 | 2001-06-27 | Merck Sharp & Dohme | Therapeutic agents |
| KR101075812B1 (ko) * | 2002-12-18 | 2011-10-25 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제 억제제로서의 트리아졸로피리다진 |
| WO2006061428A2 (en) * | 2004-12-10 | 2006-06-15 | Universität Zürich | Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain |
| US8501738B2 (en) | 2009-06-23 | 2013-08-06 | Concert Pharmaceuticals, Inc. | Substituted triazolo-pyridazine derivatives |
| EP2456311A4 (en) * | 2009-07-24 | 2013-01-23 | Concert Pharmaceuticals Inc | SUBSTITUTED IMIDASOTRIAZINES |
| US8278460B2 (en) | 2009-10-15 | 2012-10-02 | Concert Pharmaceuticals, Inc. | Substituted benzimidazoles |
| SG182297A1 (en) | 2009-12-31 | 2012-08-30 | Ct Nac Investigaciones Oncologicas Cnio | Tricyclic compounds for use as kinase inhibitors |
| WO2012098387A1 (en) * | 2011-01-18 | 2012-07-26 | Centro Nacional De Investigaciones Oncológicas (Cnio) | 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
| JP6042438B2 (ja) | 2011-09-27 | 2016-12-14 | ジェンフィットＧｅｎｆｉｔ | Ｒｅｖ−ｅｒｂアゴニストとしての６−置換トリアゾロピリダジン類の誘導体 |
| UA125463C2 (uk) | 2016-01-27 | 2022-03-16 | Універсітет Цюріх | ЗАСТОСУВАННЯ МОДУЛЯТОРІВ GABA<sub>A</sub>-РЕЦЕПТОРА ДЛЯ ЛІКУВАННЯ СВЕРБЕЖУ |
| AU2019255282B2 (en) * | 2018-04-18 | 2024-08-08 | Neurocycle Therapeutics, Inc. | Gabaa positive allosteric modulator compounds, methods of making, and uses thereof |
| HUE060943T2 (hu) * | 2018-09-13 | 2023-04-28 | Saniona As | A gaba A receptor ligandum |
| HU231223B1 (hu) | 2018-09-28 | 2022-01-28 | Richter Gedeon Nyrt. | GABAA A5 receptor modulátor hatású biciklusos vegyületek |
| WO2021191837A1 (en) | 2020-03-26 | 2021-09-30 | Richter Gedeon Nyrt. | 1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa α5 receptor modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE236904T1 (de) * | 1996-07-25 | 2003-04-15 | Merck Sharp & Dohme | Substituierte triazolo-pyridazin-derivate als liganden von gaba-rezeptoren |
-
1998
- 1998-06-24 GB GBGB9813576.7A patent/GB9813576D0/en not_active Ceased
-
1999
- 1999-06-15 AT AT99929508T patent/ATE239730T1/de not_active IP Right Cessation
- 1999-06-15 AU AU46301/99A patent/AU757315B2/en not_active Ceased
- 1999-06-15 EA EA200100071A patent/EA003332B1/ru not_active IP Right Cessation
- 1999-06-15 RS YUP-778/00A patent/RS49746B/sr unknown
- 1999-06-15 KR KR1020007014680A patent/KR100604108B1/ko not_active IP Right Cessation
- 1999-06-15 TR TR2000/03789T patent/TR200003789T2/xx unknown
- 1999-06-15 WO PCT/GB1999/001897 patent/WO1999067245A1/en active IP Right Grant
- 1999-06-15 PL PL345332A patent/PL204650B1/pl not_active IP Right Cessation
- 1999-06-15 HU HU0102894A patent/HUP0102894A3/hu unknown
- 1999-06-15 IL IL13977599A patent/IL139775A0/xx active IP Right Grant
- 1999-06-15 EE EEP200000767A patent/EE200000767A/xx unknown
- 1999-06-15 NZ NZ508290A patent/NZ508290A/en unknown
- 1999-06-15 US US09/719,184 patent/US6630471B1/en not_active Expired - Lifetime
- 1999-06-15 CN CNB998078352A patent/CN1138779C/zh not_active Expired - Fee Related
- 1999-06-15 BR BR9911563-8A patent/BR9911563A/pt not_active Application Discontinuation
- 1999-06-15 EP EP99929508A patent/EP1090004B1/en not_active Expired - Lifetime
- 1999-06-15 JP JP2000555898A patent/JP4749545B2/ja not_active Expired - Fee Related
- 1999-06-15 CZ CZ20004872A patent/CZ291409B6/cs not_active IP Right Cessation
- 1999-06-15 SK SK1955-2000A patent/SK285307B6/sk not_active IP Right Cessation
- 1999-06-15 ES ES99929508T patent/ES2196824T3/es not_active Expired - Lifetime
- 1999-06-15 GE GEAP19995726A patent/GEP20033143B/en unknown
- 1999-06-15 ID IDW20002717A patent/ID27771A/id unknown
- 1999-06-15 CA CA002335328A patent/CA2335328C/en not_active Expired - Fee Related
- 1999-06-15 DE DE69907675T patent/DE69907675T2/de not_active Expired - Lifetime
- 1999-06-16 MY MYPI99002465A patent/MY124341A/en unknown
- 1999-06-18 CO CO99038282A patent/CO5031239A1/es unknown
- 1999-06-22 PE PE1999000557A patent/PE20000710A1/es not_active Application Discontinuation
- 1999-06-23 AR ARP990103008A patent/AR018925A1/es active IP Right Grant
- 1999-06-28 TW TW088110866A patent/TWI222449B/zh active
-
2000
- 2000-11-20 IL IL139775A patent/IL139775A/en not_active IP Right Cessation
- 2000-11-24 IS IS5730A patent/IS2258B/is unknown
- 2000-12-14 ZA ZA200007485A patent/ZA200007485B/en unknown
- 2000-12-18 HR HR20000879A patent/HRP20000879A2/hr not_active Application Discontinuation
- 2000-12-21 NO NO20006576A patent/NO317992B1/no not_active IP Right Cessation
-
2001
- 2001-01-15 BG BG105152A patent/BG64989B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR018925A1 (es) | Derivados de triazolo-piridazina como ligandos para receptores de gaba, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento. | |
| DE69830503D1 (de) | Tablette mit verlängerter wirkstoffabgabe zur behandlung der parkinsonkrankheit | |
| ID22746A (id) | Senyawa-senyawa baru | |
| CA2086434A1 (en) | Quinuclidine derivatives | |
| CA2309629A1 (en) | Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters | |
| YU73991A (sh) | POSTUPAK ZA DOBIJANJE 2-METIL-10-(4-METIL-1-PIPERAZINIL)-4H- TIENO 2,3-b 1,5 BENZODIAZEPINA | |
| IL134111A0 (en) | Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation | |
| GEP20033081B (en) | Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas | |
| FR2795646B1 (fr) | Article manufacture pour un usage pharmaceutique humain | |
| NO20013645D0 (no) | Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjonen av perifere benzodiazepinreseptorer | |
| AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
| ATE194347T1 (de) | Imidazo(1,2-a)quinoxalin-4-amine als adenosin- antagonisten, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| ATE35266T1 (de) | 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5,6dihydro-5-methyl-6-oxo-4h-imidazo(1,5a)(1,4)benzodiazepin, verfahren zu seiner herstellung und pharmazeutische zubereitungen. | |
| UA50720C2 (uk) | 2,7-заміщені похідні октагідро-1н-піридо[1,2a]піразину, фармацевтична композиція та спосіб лікування | |
| JP3015129B2 (ja) | ベンゾジアゼピン化合物を用いる新規治療法 | |
| FI922874A0 (fi) | Aminometyl-substituerade 2,3- dihydropyrano/2,3-b/pyridiner, foerfarande foer framstaellning av dessa och anvaendning av dessa i laekemedel. | |
| Weiss et al. | Adenosine antagonists: lack of effect on the inhibition of kindled seizures in rats by carbamazepine | |
| JPS6463521A (en) | Trapidyl-containing drug composition, manufacture and related therapeutical use | |
| ATE2272T1 (de) | 9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2b)thiophen-4,9-imine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| JPS57167922A (en) | Psychotropic drug | |
| AR036011A1 (es) | Compuestos derivados imidazo-pirimidina como ligandos para los receptores de gaba,composiciones farmaceuticas, uso en la preparacion de medicamentos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |